Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
licensing
Biotech
Astellas bets more than $800M on Kelonia's delivery tech
Kelonia's deal with Astealls marks the biotech's first big partnership since launching in April 2022.
Max Bayer
Feb 15, 2024 6:30pm
Voyager asset lands on planet Alexion after Pfizer handoff
Nov 6, 2023 4:01pm
ADARx preps 3rd clinical program and mulls IPO
Oct 3, 2023 10:55am
BMS trims anti-TIGIT and a handful of other meds
Sep 14, 2023 1:57pm
Exelixis dips into the AI game, LIB cashes in on PCSK9
Sep 12, 2023 11:00am
Janssen sticks with Cidara's flu med, but plans to sell it off
Sep 6, 2023 11:39am